Page last updated: 2024-11-03

prazosin and Carcinoma, Medullary

prazosin has been researched along with Carcinoma, Medullary in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuchs, R1
Schwach, G1
Stracke, A1
Meier-Allard, N1
Absenger, M1
Ingolic, E1
Haas, HS1
Pfragner, R1
Sadjak, A1

Other Studies

1 other study available for prazosin and Carcinoma, Medullary

ArticleYear
The anti-hypertensive drug prazosin induces apoptosis in the medullary thyroid carcinoma cell line TT.
    Anticancer research, 2015, Volume: 35, Issue:1

    Topics: Antihypertensive Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Medullary; Cell Line, Tumor; D

2015